---
annotations:
- id: PW:0000718
  parent: regulatory pathway
  type: Pathway Ontology
  value: p53 signaling pathway
- id: PW:0000303
  parent: regulatory pathway
  type: Pathway Ontology
  value: p53-dependent G1/S DNA damage checkpoint pathway
authors:
- I379077
- AlexanderPico
- MaintBot
- Mkutmon
- Jildau
- MartijnVanIersel
- AllanKuchinsky
- Christine Chichester
- Zari
- Ryanmiller
- Asios Olia
- Khanspers
- Fehrhart
- L Dupuis
- Finterly
- Eweitz
- Egonw
citedin:
- link: PMC8261657
  title: Biological and clinical features of triple negative Invasive Lobular Carcinomas
    of the breast. Clinical outcome and actionable molecular alterationsâ˜† (2021)
- link: PMC5628161
  title: MicroRNA expression profiling of Xp11 renal cell carcinoma (2017)
- link: PMC9675776
  title: GediNET for discovering gene associations across diseases using knowledge
    based machine learning approach (2022)
- link: PMC9614744
  title: Shared mechanisms and crosstalk of COVID-19 and osteoporosis via vitamin
    D (2022)
- link: 10.1038/s41467-024-47085-y
  title: A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis
    reveals bioenergetic insights into disease pathogenesis (2024)
- link: 10.1016/j.tiv.2016.03.009
  title: MicroRNAs as potential biomarkers for doxorubicin-induced cardiotoxicity
- link: 10.3389/fimmu.2021.769011
  title: 'A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin
    Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics
    Analysis (2024)'
- link: 10.47717/turkjsurg.2025.2025-3-33
  title: 'Genetic profiling and pathway analysis in bladder carcinoma: Implications
    for therapeutic targeting (2025)'
- link: PMC12301734
  title: Investigating Transcriptional Age Acceleration in Inflammatory Skin Diseases
- link: PMC12174437
  title: Serum extracellular vesicle microRNAs as potential biomarkers to predict
    pembrolizumab response and prognosis in metastatic non-small cell lung cancer
    patients (2025)
communities:
- CPTAC
- PancCanNet
description: This is one of two pathways that deal with DNA damage. It has two central
  gene products (ATM and TP53) which are connected with the [other DNA damage response
  pathway](https://www.wikipathways.org/pathways/WP707.html). In this pathway there
  is only one source of DNA damage induction, since most DNA damage induction sources
  and their involvement are mentioned in the [first DNA damage response pathway](https://www.wikipathways.org/pathways/WP707.html).
  If it is not mentioned differently, the processes take place in the cell cytoplasm.
  The purpose of this pathway is to report more gene products and cell condition changes
  through the DNA damage response pathway and at the same time keep them clearly arranged.  Proteins
  on this pathway have targeted assays available via the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP710)
last-edited: 2025-11-04
ndex: 73cd1c9f-8b62-11eb-9e72-0ac135e8bacf
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP710
- /instance/WP710
- /instance/WP710_r141135
revision: r141135
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP710.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: This is one of two pathways that deal with DNA damage. It has two central
    gene products (ATM and TP53) which are connected with the [other DNA damage response
    pathway](https://www.wikipathways.org/pathways/WP707.html). In this pathway there
    is only one source of DNA damage induction, since most DNA damage induction sources
    and their involvement are mentioned in the [first DNA damage response pathway](https://www.wikipathways.org/pathways/WP707.html).
    If it is not mentioned differently, the processes take place in the cell cytoplasm.
    The purpose of this pathway is to report more gene products and cell condition
    changes through the DNA damage response pathway and at the same time keep them
    clearly arranged.  Proteins on this pathway have targeted assays available via
    the [CPTAC Assay Portal](https://assays.cancer.gov/available_assays?wp_id=WP710)
  keywords:
  - ABL1
  - AKT1
  - AKT2
  - AKT3
  - APC
  - ATM
  - AXIN1
  - BAD
  - BAK1
  - BAX
  - BBC3
  - BCL2
  - BCL2L11
  - BCL6
  - BIK
  - CAT
  - CCND1
  - CCND2
  - CCND3
  - CCNG2
  - CDC42
  - CDKN1A
  - CDKN1B
  - CDKN2A
  - CTNNB1
  - DVL1
  - DVL2
  - DVL3
  - ERBB2
  - FASLG
  - FOSL1
  - FOXO3
  - FRAT1
  - G6PC
  - GRB2
  - GSK3B
  - HMGB1
  - HRAS
  - INSR
  - IRS1
  - JUN
  - KRAS
  - LDLR
  - LEF1
  - MAP3K1
  - MAP3K4
  - MAP3K7
  - MAPK10
  - MAPK2
  - MAPK8
  - MAPK9
  - MDM2
  - MLKL
  - MYC
  - NFKB1
  - NFKB2
  - NRAS
  - PDK1
  - PEPCK
  - PIK3C2A
  - PIK3C2B
  - PIK3C2G
  - PIK3C3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R1
  - PIK3R2
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PLAU
  - PMAIP1
  - PPP2R5C
  - PPP2R5E
  - PTEN
  - RAC1
  - RAC2
  - RAC3
  - RBL2
  - RHOA
  - SCP2
  - SHC1
  - SMAD3
  - SMAD4
  - SOD2
  - SOS1
  - SOS2
  - TCF-1
  - TCF-3
  - TCF-4
  - TGFB
  - TGFB1
  - TP53
  - TP73
  - WNT1
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT5A
  - WNT5B
  - WNT6
  - WNT7A
  - WNT7B
  - c-Myc
  license: CC0
  name: DNA damage response (only ATM dependent)
seo: CreativeWork
title: DNA damage response (only ATM dependent)
wpid: WP710
---